Chemung Financial Corporation (NASDAQ:CHMG) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with -0.77% to $36.19. Chemung Financial Corp. (CHMG) reported that appointment of Anders Tomson as President and Chief Executive Officer of the company and its banking unit Chemung Canal Trust Co. effective immediately. Tomson, 49, replaces Ronald Bentley who retired as CEO on December 22. The transition had been previously reported in May at the annual shareholders’ meeting.
Tomson was also elected to the Board of Directors of Chemung Financial and Chemung Canal Trust. He will stand for shareholder election at the Corp.’s annual shareholders’ meeting in May 2017.In July 2015 Tomson was named President and Chief Operating Officer of Chemung Canal Trust as part of a succession plan anticipating Bentley’s retirement. The share price of CHMG attracts active investors, as stock price of week volatility recorded 2.95%. The stock is going forward to its 52-week low with 43.55% and lagging behind from its 52-week high price with -1.52%.
Cardinal Health, Inc. (NYSE:CAH) [Trend Analysis] moved up reacts as active mover, shares a gain 1.07% to traded at $72.88 and the percentage gap between open changing to regular change was 0.35%. Cardinal Health Inc. decided to pay $34 million in civil penalties to settle allegations that it failed to report suspicious drug orders sent from its distribution center in Lakeland to pharmacies in Florida and in Maryland.
The Florida settlement, and a related $10 million settlement in New York, resolve the outstanding civil penalty portion of the company’s 2012 administrative settlement with the U.S. Drug Enforcement Agency, Cardinal (NYSE:CAH), said in a press release. See the Florida settlement contract below. The 2012 settlement resulted in a two-year suspension of Cardinal’s registration to distribute Class II narcotics from the Lakeland distribution center.
The firm’s current ratio calculated as 1.10 for the most recent quarter. The firm past twelve months price to sales ratio was 0.19 and price to cash ratio remained 11.65. As far as the returns are concern, the return on equity was recorded as 20.40% and return on investment was 13.30% while its return on asset stayed at 4.00%. The firm has total debt to equity ratio measured as 0.85.